¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cytotoxic substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytotoxic
    ¼¼Æ÷µ¶¼º-
  • cytotoxic agent
    ¼¼Æ÷µ¶¼ºÁ¦
  • cytotoxic antibody
    ¼¼Æ÷µ¶¼ºÇ×ü
  • cytotoxic cell
    ¼¼Æ÷µ¶¼º¼¼Æ÷
  • cytotoxic cell protein
    ¼¼Æ÷µ¶¼º¼¼Æ÷´Ü¹éÁú
  • cytotoxic chemotherapy
    ¼¼Æ÷µ¶¼ºÈ­Çпä¹ý
  • cytotoxic drug
    ¼¼Æ÷µ¶¼º¾à¹°
  • cytotoxic edema
    ¼¼Æ÷µ¶¼ººÎÁ¾
  • cytotoxic hypersensitivity
    ¼¼Æ÷µ¶¼º°ú¹Î¼º
  • cytotoxic hypoxia
    ¼¼Æ÷µ¶¼ºÀú»ê¼ÒÁõ
  • cytotoxic killer T cell
    ¼¼Æ÷µ¶¼º»ìÇØT¼¼Æ÷
  • cytotoxic reaction
    ¼¼Æ÷µ¶¼º¹ÝÀÀ
  • antibacterial substance
    Ç×±Õ¹°Áú
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • carcinogenic substance
    ¹ß¾Ï¹°Áú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytotoxic chemotherapy
    Ç×¾ÏÈ­Çпä¹ý
  • substance
    ¹°Áú, Áú
  • antibacterial substance
    Ç×±Õ¹°Áú
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
  • odoriferous substance
    Çâ·á
  • pyrogenic substance
    ¹ß¿­¹°Áú
  • reaction substance
    ¹ÝÀÀ¹°Áú
  • reserve substance
    ÀúÀå¹°Áú
  • spongy substance
    ÇØ¸éÁú
  • toxic substance
    µ¶¼º¹°Áú
  • substance withdrawal
    ¹°Áú±Ý´Ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytotoxic agent
    ¼¼Æ÷µ¶¼ºÁ¦
  • cytotoxic antibody
    ¼¼Æ÷µ¶¼ºÇ×ü
  • cytotoxic
    ¼¼Æ÷µ¶¼º-
  • cytotoxic cell
    ¼¼Æ÷µ¶¼º¼¼Æ÷
  • cytotoxic drug
    ¼¼Æ÷µ¶¼º¾à¹°
  • cytotoxic edema
    ¼¼Æ÷µ¶¼ººÎÁ¾
  • cytotoxic hypersensitivity
    ¼¼Æ÷µ¶¼º°ú¹Î
  • cytotoxic hypoxia
    ¼¼Æ÷µ¶¼ºÀú»ê¼ÒÁõ
  • cytotoxic reaction
    µ¶¼º¹ÝÀÀ, ¼¼Æ÷µ¶¼º¹ÝÀÀ
  • cytotoxic cell protein
    ¼¼Æ÷µ¶¼º¼¼Æ÷´Ü¹é
  • accelerans substance
    ÃËÁø¹°Áú
  • accessory food substance
    ºÎ¿µ¾ç¹°Áú
  • acrosomal substance
    ÷´Üü¹°Áú
  • agglutinable substance
    ÀÀÁý¼º¹°Áú
  • antibacterial substance
    Ç×±Õ¹°Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cytotoxic
    ¼¼Æ÷µ¶¼º(á¬øàÔ¸àõ)
  • antibody, cytotoxic
    ¼¼Æ÷µ¶¼ºÇ×ü
  • ground substance amorphous substance
    ¹«ÇüÁú
  • C-substance
    C-¹°Áú.
  • EPS=£¾exophthalmos producing substance
    ¾È±¸µ¹ÃâÀ¯¹ß¹°Áú.
  • Goitrogenic substance
    °©»ó¼±Á¾À¯¹ß¹°Áú(Ë£ßÒàÍðþë¯Û¡Úªòõ)
  • Inducer substance
    À¯µµ¹°Áú(ë¯ÓôÚªòõ)
  • Inhibitor substance
    ¾ïÁ¦¹°Áú(åäð¤Úªòõ)
  • Kerry reducing substance test
    Äɸ®È¯¿ø¹°Áú½ÃÇè
  • Mullerian inhibiting substance
    ¹°·¯°ü ¾ïÁ¦¹°Áú
  • P substance
    P¹°Áú
  • SRS A : slow reacting substance A
    ¿¡½º¾Ë¿¡½º-¿¡ÀÌ.
  • accelerans substance
    ÃËÁø¹°Áú(õµòäÚªòõ).
  • accessory food substance
    ºÎ¿µ¾ç¹°(Üùç½å×Úª).
  • acrosomal substance
    ÷´Üü¹°Áú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytotoxic substance =cytotoxin
    µ¶(¼Ò)(á¬øàÔ¸áÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ground substance amorphous substance
    ¹«ÇüÁú
  • antibody, cytotoxic
    ¼¼Æ÷µ¶¼ºÇ×ü
  • cytotoxic
    <¾à¹°>, ¼¼Æ÷µ¶¼º(¡­Ô¸àõ)ÀÇ.
  • cytotoxic
    ¼¼Æ÷µ¶¼º(¡­Ô¸àõ)ÀÇ.
  • cytotoxic T cell
    ¼¼Æ÷µ¶¼º T ¼¼Æ÷
  • cytotoxic T cell
    ¼¼Æ÷µ¶¼ºT¼¼Æ÷
  • cytotoxic T lymphocyte (CTL)
    ¼¼Æ÷µ¶¼ºT¸²ÇÁ±¸
  • cytotoxic T-cell ; killer T-cell
    (¼¼Æ÷)»ì(ÇØ) T¼¼Æ÷.
  • cytotoxic action
    ¼¼Æ÷µ¶ÀÛ¿ë.
  • cytotoxic agent
    ¼¼Æ÷ µ¶¼ºÁ¦
  • cytotoxic antibody
    ¼¼Æ÷µ¶¼ºÇ×ü.
  • cytotoxic antibody
    °ú¼¼Æ÷µ¶Ç×ü, ¼¼Æ÷µ¶¼ºÇ×ü.
  • cytotoxic antitumor antibody
    ¼¼Æ÷µ¶¼ºÇ×Á¾¾çÇ×ü
  • cytotoxic cell protein
    ¼¼Æ÷µ¶¼º ¼¼Æ÷´Ü¹é
  • cytotoxic drug
    ¼¼Æ÷µ¶¼º¾à¹°.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ground substance [Amorphous substance]
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ±âÁú
  • Lateral intermediate substance
    °¡ÂÊÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£Áú¿ÜÃøºÎ
  • Proper substance of cornea
    °¢¸·°íÀ¯Áú
    [¿¾ ¿ë¾î] °¢¸·°íÀ¯Áú
  • Proper substance of sclera
    °ø¸·°íÀ¯Áú
    [¿¾ ¿ë¾î] °ø¸·°íÀ¯Áú
  • Muscular substance
    ±ÙÀ°Áú
    [¿¾ ¿ë¾î] ±ÙÁú
  • Chromophilic substance [Nissl body]
    ´Ö½½¼Òü
    [¿¾ ¿ë¾î] ´Ö½½¼Òü
  • Posterior perforated substance
    µÚ°üÅëÁú
    [¿¾ ¿ë¾î] ÈÄÀ¯°øÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ±âÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] »ó¾ÆÁú±âÁú
  • Fundamental substance
    ¹«ÇüÁú
    [¿¾ ¿ë¾î] ¿¬°ñ±âÁú
  • White substance
    ¹é»öÁú
    [¿¾ ¿ë¾î] ¹éÁú
  • Cortical substance
    »À°ÑÁú
    [¿¾ ¿ë¾î] ÇÇÁú
  • Fibrinoid substance
    ¼¶À¯¼Ò¼º¹°Áú
    [¿¾ ¿ë¾î] À¯¼¶À¯¼ÒÁú
  • Reticular substance
    ¼¼¸ÁÁú
    [¿¾ ¿ë¾î] ¼¼¸ÁÁú
  • Intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
    [¿¾ ¿ë¾î] ¼¼Æ÷°£Áú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytotoxic anaphylaxis
    ¼¼Æ÷µ¶¼º(á¬øàÔ¸àõ) ¾Æ³ªÇʶô½Ã½º
  • cytotoxic antibody
    ¼¼Æ÷µ¶¼º Ç×ü(á¬øàÔ¸àõù÷ô÷)
  • cytotoxic T cell
    ¼¼Æ÷µ¶¼º(á¬øàÔ¸àõ) T ¼¼Æ÷(á¬øà)
  • C substance
    C ¹°Áú(Úªòõ)
  • ferredoxin reducing substance
    Æä¸®µ¶½Å ȯ¿ø ¹°Áú(ü½êªÚªòõ)
  • ground substance
    ¹ÙÅÁ¹°Áú(Úªòõ)
  • pectic substance
    Æåƾ ¹°Áú(Úªòõ)
  • photodynamic substance
    ±¤¿ªÇÐ ¹°Áú(Úªòõ)
  • queen substance
    ¿©¿ÕºÀ(Ò³èÝÜð) ¹°Áú(Úªòõ)
  • rabbit aorta contracting substance
    Åä³¢ ´ëµ¿¸Æ ¼öÃ๰Áú(ÓÞÔÑØæâ¥õêÚªòõ)
  • slow-reacting substance
    ¿Ï¼Ó(èÐáÜ) ¹ÝÀÀ¹°(ÚãëëÚª)
  • substance P
    P ¹°Áú(Úªòõ)
  • threshold substance
    ¹®Åι°Áú(Úªòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytotoxic
    ¼¼Æ÷µ¶¼º ¹°Áú, ¼¼Æ÷µ¶¼ºÀÇ
  • anterior perforated substance
    ÀüÀ¯°ø¹°Áú
  • ferromagnetic substance
    öÀÚ¼ºÃ¼, °­ÀÚ¼ºÃ¼
  • gray substance
    ȸ»öÁú
  • nerve transmitter substance
    ½Å°æÀü´Þ¹°Áú
  • paramagnetic substance
    »óÀÚ¼º¹°Áú
  • radioactive substance
    ¹æ»ç¼º¹°Áú
  • substance
    ¹°Áú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MIS management information system; medical information service; meiosis-inducing substance; minimally in...
Tc cell cytotoxic T cell
ACS acrocallosal syndrome; acrocephalosyndactyly; acute chest syndrome; acute confusional state; Alcon C...
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
CI cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ADCC Antibody dependent cellular cytotoxic
CTL Cytotoxic T Lymphocytes
CTX Cytotoxic
CNF1 Cytotoxic Necrotizing Factor 1
Tc T cytotoxic
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cytotoxic substance
    ¼¼Æ÷ µ¶, ¼¼Æ÷µ¶¼Ò
    µ¿ÀǾî=cytotoxin.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cytotoxic
    ¼¼Æ÷ µ¶¼º
    ¼¼Æ÷ µ¶¼Ò¿¡ ÀÇÇÑ. ¼¼Æ÷ µ¶ ÀÛ¿ëÀ» Áö´Ñ.
  • cytotoxic antibody
    ¼¼Æ÷ µ¶ Ç×ü, ¼¼Æ÷ µ¶¼º Ç×ü
  • cytotoxic factor
    ¼¼Æ÷ µ¶¼º ÀÎÀÚ
  • humoral cytotoxic antibody
    ü¾×¼º ¼¼Æ÷ µ¶¼º Ç×ü
  • T cell cytotoxic
    T ¼¼Æ÷ µ¶¼º
  • accelerans substance
    ÃËÁø¹°Áú
    ½ÉÀå ½Å°æ ÀÛ¿ëÀÇ ¾×ü Àüµµ¿¡ À־, ÃËÁø ½Å°æÀ» ÀÚ±ØÇÔÀ¸·Î½á »ý±â´Â ½É¹Ú Áõ°¡¼º À§¿îµ¿ ¾ïÁ¦¼º ¹°Áú.
  • accessory food substance
    ºÎ¿µ¾ç¹°
  • accessory growth substance
    ¹ßÀ° º¸Á¶ ¹°Áú
    ¹ßÀ°À» Çϴµ¥ º¸Á¶µÇ´Â ¹°Áú.
  • agglutinable substance
    ÀÀÁý¼º ¹°Áú
  • anti-intercellular substance antibody
    Ç×¼¼Æ÷°£ ¹°Áú Ç×ü
  • ascending substance P
    »óÇà P ¹°Áú
  • bone inducing substance
    °ñ Çü¼º À¯µµ ÀÎÀÚ
  • bone substance
    °ñÁú
  • cement substance
    Á¢ÇÕ ¹°Áú
    µÎ °³ÀÇ Ç¥¸éÀ» °ß°íÇÏ°Ô Á¢ÇÕÇÏ´Â ¹°Áú.
  • coagualtion-active substance
    ÀÀ°í Ȱ¼º ¹°Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
antireticular cytotoxic serum An antiserum specific for cells of the reticuloendothelial system.
(05 Mar 2000)
cytotoxic <pharmacology> Chemicals that are directly toxic to cells, preventing their reproduction or growth. Cytotoxic agents can, as a side effect, damage healthy, noncancerous tissues or organs which have a high proportion of actively dividing cells, for example, bone marrow, hair follicles. These side effects limit the amount and frequency of drug administration.
(16 Dec 1997)
cytotoxic cell Cells of the immune system that inhibit or help to terminate an immune response, e.g., suppressor macrophages and suppressor T-cells.
Synonym: cytotoxic cell.
(05 Mar 2000)
cytotoxic drugs <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells.
See: chemotherapy.
(13 Nov 1997)
cytotoxic reaction An immunologic (allergic) reaction in which noncytotropic IgG or IgM antibody combines with specific antigen on cell surfaces; the resulting complex initiates the activation of complement which causes cell lysis or other damage, or which, in the absence of complement, may lead to phagocytosis or may enhance T lymphocyte involvement.
(05 Mar 2000)
cytotoxic T-cell <haematology, immunology> Subset of T lymphocytes (mostly CD8) responsible for lysing target cells and for killing virus infected cells (in the context of Class I histocompatibility antigens).
(18 Nov 1997)
cytotoxic t-lymphocyte A type of CD8 or, less often, CD4 lymphocyte that kills diseased cells infected by a specific virus or other intracellular microbe. CTLs interact with MHC class I receptors (see Major Histocompatibility Complex). On infected cells and have the prime role in cellmediated immunity (see). Cytovene:
See: Ganciclovir.
(09 Oct 1997)
cytotoxic T lymphocyte-specific serine protease <enzyme> Structural sequence given in first source
Registry number: EC 3.4.21.-
Synonym: cytotoxic t lymphocyte-specific serine protease ccp I, cytotoxic t lymphocyte specific serine protease ccp II, mast cell protease type II
(26 Jun 1999)
T cytotoxic cells Lymphocyte-like effector cells which mediate antibody-dependent cell cytotoxicity. They kill antibody-coated target cells which they bind with their fc receptors.
(12 Dec 1998)
T-lymphocytes, cytotoxic Immunised T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (mlc), in vivo during a graft-versus-host (gvh) reaction, or after immunization with an allograft, tumour cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (cml). These cells are distinct from natural killer cells (killer cells, natural) and from killer cells mediating antibody-dependent cell cytotoxicity.
(12 Dec 1998)
alpha substance A filamentous plasmatic material, beaded with granules, demonstrable by means of vital staining in the immature red blood cells.
Synonym: alpha substance, filar mass, filar substance, substantia reticularis, substantia reticulofilamentosa.
Synonym: reticular formation.
(05 Mar 2000)
anterior perforated substance A region at the base of the brain through which numerous small branches of the anterior and middle cerebral arteries (lenticulostriate arteries) enter the depth of the cerebral hemisphere; it is bordered medially by the optic chasm and anterior half of the optic tract, rostrally and laterally by the lateral olfactory stria; its anteromedial part corresponds to the olfactory tubercle.
Synonym: substantia perforata anterior, locus perforatus anticus, olfactory area.
(05 Mar 2000)
autacoid substance A substance formed metabolically by one set of cells, which alters the function of other cells. (This term is sometimes used in place of the term hormone.)
(05 Mar 2000)
bacteriotropic substance Opsonin or other substance that alters bacterial cells in such a manner that they are more susceptible to phagocytic action.
(05 Mar 2000)
basophilic substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • in substance
    »ç½Ç»ó,½ÇÁúÀûÀ¸·Î
  • substance
    ¹°Áú,½Çü,º»Ã¼,º»Áú,³»¿ë,¾Ë¸ÍÀÌ,¼ºÁú,Àç»ê,ÀÚ»ê
  • the substance
    ´ëºÎºÐ
  • controlled substance
    ±ÔÁ¦ ¾à¹°(¼ÒÁö¹× »ç¿ëÀÌ ±ÔÁ¦µÇ´Â ¾à¹°)
  • substance
    ¹°Áú;(¾î¶² Á¾·ùÀÇ)¹°°Ç;½Çü;º»Áú;¿äÁö;½ÇÁú;Àç»ê;in ~ ´ëü·Î;½ÇÁúÀûÀ¸·Î;»ç½Ç»ó
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á